ABVC icon

ABVC BioPharma

9 hedge funds and large institutions have $817K invested in ABVC BioPharma in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 2 closing their positions.

Holders
9
Holders Change
-1
Holders Change %
-10%
% of All Funds
0.12%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
5
Reduced
2
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
Vanguard Group
1
Vanguard Group
Pennsylvania
$248K 111,533 +64,586 +138%
Geode Capital Management
2
Geode Capital Management
Massachusetts
$246K 110,499 +6,017 +6%
XT
3
XTX Topco
Cayman Islands
$117K 52,625 -7,814 -13%
Renaissance Technologies
4
Renaissance Technologies
New York
$92.8K 41,706 +41,706 New
Northern Trust
5
Northern Trust
Illinois
$82.6K 37,144 +18,009 +94%
State Street
6
State Street
Massachusetts
$28.7K 12,900
SS
7
SBI Securities
Japan
$1.08K 483 +23 +5%
TRCT
8
Tower Research Capital (TRC)
New York
$788 354 -2,222 -86%
Bank of America
9
Bank of America
North Carolina
$296 133 +48 +56%
UBS Group
10
UBS Group
Switzerland
-29,003 Closed
TSS
11
Two Sigma Securities
New York
-11,470 Closed